Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 1:09 PM

Jim Birchenough

Type: Person
Name: Jim Birchenough
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents (in Health)
Food and Drug Administration - Click to view 360-page
Food and Drug Administration
Lupus drug headed to FDA after hitting key targets
The latest round of studies on the experimental drug Benlysta showed that a sufficient number of lupus patients given a higher dosage of the drug showed improvement after a year, which enabled the drug to meet its target. A lower dosage of the drug did ... [Washington Post - 11/03/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents (in Health)
Advancement made in experimental lupus treatment
Increases the bookmarktwitterfacebookdiggGoogleWindowsliveDeliciousbuzzfriendfeedLinkedindiigoredditstumbleuponRockville-based Human Genome Sciences, a listed biotechnology company in U.S., announced Monday that its experimental lupus treatment passed ... [People's Daily Online - 11/03/2009]

Quotes

"we continue to see significant risk to confirmation of bliss-52 results and would take a wait-and-see approach" said Jim Birchenough, an analyst at Barclays Capital, in a research note
PREVIEW-Human Genome poised for biggest day in its history [FinanzNachrichten.de - 10/30/2009]

More Content

All (13) | News (12) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0)
In Focus
  •  
Henri Termeer, Roger Perlmutter, Randy Scott, [more]
  •  
Barclays Capital Inc, Human Genome Sciences Inc, Amgen Inc, [more]
  •  
Food and Drug Administration, University of Delaware, University of Pennsylvania Wharton Sc ..., [more]
  •  
Systemic Lupus Erythematosus, Tysabri, Biotechnology, [more]
  •  
Framingham (United States), Boston (Massachusetts, United States), Halle (Belgium), [more]
  •  
United States, Belgium, Germany, [more]
  •  
Medicine, Biology, Research & Development, [more]
  •  
Pharma & Biotech, Health, Chemicals & Plastics
Seeking Alpha, WSJ.com: Health Blog, People's Daily Online, [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Five Positive Signs for Cash-Strapped Biotech I... [WSJ.com: Health Blog - 05/28/2009]
Cloudy days are starting to turn brighter for the biotech industry, many of whose smaller players have been strapped for cash amid the recession. A run-down of recent ...
1

  •  
  •  
  •